98%
921
2 minutes
20
Psoriasis is an autoimmune-mediated disease with several comorbidities in addition to typical skin lesions. Increasing evidence shows the relationships between psoriasis and renal functions, but the relationship and causality remain unclear. We aimed to investigate the associations and causality between psoriasis and four renal functions, including the estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), urine albumin to creatinine ratio (UACR), and chronic kidney disease (CKD). For the population-based study, we analyzed the National Health and Nutrition Examination Survey (NHANES) data from five cycles (2003-2006 and 2009-2014) on psoriasis and renal functions. Subgroup analyses were conducted among different categories of participants. Meanwhile, a bidirectional two-sample Mendelian randomization (TSMR) study in European populations was also performed using summary-level genetic datasets. Causal effects were derived by conducting an inverse-variance weighted (MR-IVW) method. A series of pleiotropy-robust MR methods was employed to validate the robustness. Multivariable MR (MVMR) was conducted to complement the result when five competing risk factors were considered. A total of 20,244 participants were enrolled in the cross-sectional study, where 2.6% of them had psoriasis. In the fully adjusted model, participants with psoriasis had significantly lower eGFR ( = 0.025) compared with the healthy group. Individuals who are nonoverweight are more likely to be affected by psoriasis, leading to an elevation of BUN ( = 0.018). In the same line, TSMR showed a negative association between psoriasis and eGFR ( = 0.016), and sensitive analysis also consolidated the finding. No causality was identified between psoriasis and other renal functions, as well as the inverse causality ( > 0.05). The MVMR method further provided quite consistent results when adjusting five confounders ( = 0.042). We detected a significant negative effect of psoriasis on eGFR, with marginal association between BUN, UACR, and CKD. The adverse of psoriasis on the renal should merit further attention in clinical cares.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10813483 | PMC |
http://dx.doi.org/10.3390/biomedicines12010249 | DOI Listing |
Cureus
August 2025
Dermatology, Hôpital Privé Francheville, Perigueux, FRA.
Risankizumab (RZB) is a humanized monoclonal antibody that selectively targets interleukin-23 (IL-23). It has proven particularly effective in treating psoriasis, a common chronic inflammatory skin disease. However, its use remains poorly documented in certain populations, including patients with a history of solid organ transplantation or recent/active malignancy.
View Article and Find Full Text PDFHypertension
September 2025
Division of Genetics and Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center (VUMC), Nashville, TN. (Z.C., G.T., M.S., T.A., A.K., M.R.A.).
Background: Psoriasis is an autoimmune skin disease associated with increased incidence and severity of chronic kidney disease and hypertension. The mechanisms linking psoriasis skin inflammation with these comorbidities remain unclear.
Methods: We used flow cytometry, radiotelemetric blood pressure measurements, and histological and ELISA-based assessments of renal damage in mice with experimental psoriasis induced by keratinocyte-specific overexpression of (KC-Tie2) and their littermate controls.
J Complement Integr Med
August 2025
Graduate Studies, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.
Objectives: Psoriasis is a systematic skin disease. Treatment choice is limited due to unsatisfactory clinical efficacy. The study evaluated the safety of Deprungsith formulation following long-term administration (chronic toxicity test) and its potential modulatory effect on hepatic cytochrome P450 (CYP) enzymes in rats.
View Article and Find Full Text PDFFuture Microbiol
August 2025
Mediprobe Research Inc., London, Ontario, Canada.
Onychomycosis, a common fungal nail infection, can present unique diagnostic and therapeutic challenges in special populations including the elderly, children, individuals with diabetes, immunocompromised patients, and those with compromised organ function or psoriasis. These groups face increased susceptibility due to factors such as impaired immunity, vascular insufficiency, comorbidities, and altered nail morphology. Despite its often-benign perception, untreated onychomycosis in these populations can lead to complications, including secondary infection, ulceration, and systemic spread.
View Article and Find Full Text PDFPsoriasis (Auckl)
July 2025
Department of Dermatology and Venereology, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Moderate to severe psoriasis has been reported as an independent risk factor for IgA nephropathy (IgAN). IgAN is characterized by episodic microscopic hematuria, which can progress to end-stage renal disease (ESRD). Managing therapeutic interventions for psoriasis patients requiring dialysis due to ESRD presents significant challenges.
View Article and Find Full Text PDF